We are live on ! Find out more
C

Chescapmanager Portfolio holdings

AUM $1.12B
1-Year Est. Return 67.49%
This Fund
S&P 500
This Quarter Est. Return
+12.58%
1 Year Est. Return
+67.49%
3 Year Est. Return
+215.18%
5 Year Est. Return
+141.46%
10 Year Est. Return
–
AUM
$680M
AUM Growth
-$22.8M
Cap. Flow
-$76.3M
Cap. Flow %
-11.23%
Top 10 Hldgs %
66.57%
Holding
38
New
6
Increased
8
Reduced
4
Closed
6

Top Buys

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$20.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$19.5M
3
DLTR icon
Dollar Tree
DLTR
+$9.97M
4
TBPH icon
Theravance Biopharma
TBPH
+$6.83M
5
DISH
DISH Network Corp.
DISH
+$3.66M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$28.4M
2
EXP icon
Eagle Materials
EXP
+$10.2M
3
PVT
Pivotal Acquisition Corp.
PVT
+$9.1M
4
CI icon
Cigna
CI
+$1.83M
5
NWL icon
Newell Brands
NWL
+$1.64M

Sector Composition

Rank Sector Weight
1 Healthcare 31.86%
2 Consumer Discretionary 16.78%
3 Industrials 6.33%
4 Communication Services 6%
5 Consumer Staples 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIX
26
DELISTED
Six Flags Entertainment Corp.
SIX
$5.62M 0.83%
124,650
+18,448
+17% +$849K
PTON icon
27
Peloton Interactive
PTON
$2.71B
$5.25M 0.77%
185,000
+60,000
+48% +$1.62M
NWL icon
28
Newell Brands
NWL
$2.2B
$3.4M 0.5%
176,892
-85,407
-33% -$1.64M
PENN icon
29
CALL
PENN Entertainment
PENN
$2.83B
$2.56M 0.38%
100,000
– –
BMY.RT
30
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.65M 0.24%
+549,481
New +$1.43M
AXE
31
DELISTED
Anixter International Inc
AXE
$460K 0.07%
+5,000
New +$405K
CGC
32
Canopy Growth
CGC
$390M
$211K 0.03%
+1,000
New +$198K
PM icon
33
Philip Morris
PM
$305B
– –
-10,000
Closed -$759K
QQQ icon
34
PUT
Invesco QQQ Trust
QQQ
$449B
– –
-500,000
Closed -$94.4M
TBPH icon
35
CALL
Theravance Biopharma
TBPH
$874M
– –
-91,700
Closed -$1.79M
PVT.WS
36
DELISTED
Pivotal Acquisition Corp. Redeemable Warrants, exercisable for shares of Class A Common Stock at an
PVT.WS
– –
-832,500
Closed -$1.12M
PVT
37
DELISTED
Pivotal Acquisition Corp.
PVT
– –
-894,000
Closed -$9.1M
CELG
38
DELISTED
Celgene Corp
CELG
– –
-285,852
Closed -$28.4M
1
2

Similar funds

CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.12B AUM 32.75% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Chescapmanager's Q4 2019 Portfolio in Review

As of Q4 2019, Chescapmanager held 38 positions worth $680M, down 3.2% from $703M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Chescapmanager withdrew a net $76.3M in Q4 2019, closing 6 positions and reducing 4 holdings. Its most notable exit was Celgene Corp, an estimated $28.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Chescapmanager opened a new position in Tiffany & Co. worth $22.7M.

  • Chescapmanager's largest Q4 2019 buy was Tiffany & Co.: 170,000 shares worth $22.7M.
  • Chescapmanager added most to Theravance Biopharma in Q4 2019, an estimated $6.83M increase.
  • Chescapmanager's biggest Q4 2019 reduction was Eagle Materials, cutting an estimated $10.2M.
  • Chescapmanager fully exited Celgene Corp in Q4 2019, selling an estimated $28.4M.
  • Chescapmanager's ten largest holdings make up 67% of its $680M portfolio in Q4 2019.
  • Chescapmanager opened 6 new positions and closed 6 in Q4 2019.
  • Chescapmanager's portfolio value fell 3.2% quarter-over-quarter to $680M.

Based on Chescapmanager's 13F filing for Q4 2019, filed 12 Feb 2020.